XERS 10-Q: SEC filing

Xeris Biopharma Holdings, Inc.

Filed with the SEC on Nov 5, 2026 · accession 0001867096-26-000117

XERS filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +25.0% by the first close after the filing.

Summary of the filing

Xeris Biopharma Holdings, Inc. filed its quarterly report on Form 10-Q for the period ended November 5, 2026, accompanied by the CEO's Sarbanes-Oxley Section 302 certification.

For details, click here →How to read a 10-Q →

Key details

RegistrantXeris Biopharma Holdings, Inc.

Chief executive officer and chairman of the boardJohn Shannon

How XERS stock reacted

Close before

$10.46

Nov 4, 2026

First close after

+25.05%

$13.08

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for XERS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for XERS?

Click here

Frequently asked questions

What did XERS file with the SEC on Nov 5, 2026?

XERS filed a 10-Q (SEC filing). Xeris Biopharma Holdings, Inc. filed its quarterly report on Form 10-Q for the period ended November 5, 2026, accompanied by the CEO's Sarbanes-Oxley Section 302 certification.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did XERS stock react to this filing?

XERS closed at $10.46 before the filing and $13.08 on Nov 5, 2026 (+25.05%).

Other XERS SEC filings

Get alerts when XERS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

XERS overview XERS analysis XERS news Latest SEC filings